Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer—A clinical and pathological evaluation
2011 · Gynecologic Oncology · 151 citations
https://doi.org/10.1016/j.ygyno.2011.07.030
K
Keith McCarthy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
4.7K
Citations
35
h-index
51
i10-index
Keith McCarthy is an academic researcher from Wye Valley NHS Trust. The author has contributed to research in topics: Lymphoma Diagnosis and Treatment & Acute Lymphoblastic Leukemia research & CNS Lymphoma Diagnosis and Treatment. The author has an h-index of 35, co-authored 73 publications.
Papers by this author
worksTetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
2011 · British Journal of Cancer · 63 citations
https://doi.org/10.1038/bjc.2011.80
Observation of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mi>W</mml:mi><mml:mi>Z</mml:mi></mml:math>Production
2007 · Physical Review Letters · 41 citations
https://doi.org/10.1103/physrevlett.98.161801
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat